OraSure Technologies/$OSUR
13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX
About OraSure Technologies
OraSure Technologies Inc is a medical devices company that develops, manufactures, and distributes oral fluid diagnostic and collection devices. Its reportable segments are diagnostics and molecular solutions. The diagnostics segment produces rapid oral diagnostic tests and specimen collection devices for infectious diseases such as HIV and HCV. The molecular solutions segment specializes in kits used to collect, stabilize, and transport genetic material samples for molecular testing of both hereditary diseases and infectious diseases, such as COVID-19. The company gets majority of its sales from the molecular solutions business, derived mainly from customers in the United States.
Ticker
$OSUR
Sector
Primary listing
Employees
501
Headquarters
Website
OSUR Metrics
BasicAdvanced
$236M
-
-$0.68
0.27
-
Price and volume
Market cap
$236M
Beta
0.27
52-week high
$4.37
52-week low
$2.36
Average daily volume
566K
Financial strength
Current ratio
7.118
Quick ratio
6.151
Long term debt to equity
5.769
Total debt to equity
5.769
Interest coverage (TTM)
-28.93%
Profitability
EBITDA (TTM)
-40.962
Gross margin (TTM)
40.67%
Net profit margin (TTM)
-36.84%
Operating margin (TTM)
-38.09%
Effective tax rate (TTM)
-6.20%
Revenue per employee (TTM)
$280,000
Management effectiveness
Return on assets (TTM)
-7.24%
Return on equity (TTM)
-12.65%
Valuation
Price to revenue (TTM)
1.742
Price to book
0.63
Price to tangible book (TTM)
0.75
Price to free cash flow (TTM)
-11.994
Free cash flow yield (TTM)
-8.34%
Free cash flow per share (TTM)
-0.269
Growth
Revenue change (TTM)
-49.35%
Earnings per share change (TTM)
-289.04%
3-year revenue growth (CAGR)
-19.49%
10-year revenue growth (CAGR)
1.97%
3-year earnings per share growth (CAGR)
-8.30%
10-year earnings per share growth (CAGR)
52.38%
What the Analysts think about OSUR
Analyst ratings (Buy, Hold, Sell) for OraSure Technologies stock.
OSUR Financial Performance
Revenues and expenses
OSUR Earnings Performance
Company profitability
OSUR News
AllArticlesVideos
Exclusive: Altai Capital lays groundwork for board fight at OraSure Technologies, sources say
Reuters1 week ago
Exclusive: Healthcare entrepreneur's letter threatens 'adversarial path' after OraSure Tech rebuffs bid
Reuters3 weeks ago
OraSure Technologies received takeover bid from industry entrepreneur, sources say
Reuters2 months ago
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
Capital at risk
Upcoming events
No upcoming events
FAQs
What’s the current market cap for OraSure Technologies stock?
OraSure Technologies (OSUR) has a market cap of $236M as of September 16, 2025.
What is the P/E ratio for OraSure Technologies stock?
The price to earnings (P/E) ratio for OraSure Technologies (OSUR) stock is 0 as of September 16, 2025.
Does OraSure Technologies stock pay dividends?
No, OraSure Technologies (OSUR) stock does not pay dividends to its shareholders as of September 16, 2025.
When is the next OraSure Technologies dividend payment date?
OraSure Technologies (OSUR) stock does not pay dividends to its shareholders.
What is the beta indicator for OraSure Technologies?
OraSure Technologies (OSUR) has a beta rating of 0.27. This means that it is less volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 0.5 would mean it moves half as much as the market.